SCYNEXIS INC
Developing novel anti-fungal therapies for difficult-to-treat, drug-resistant infections.
SCYX | US
Overview
Corporate Details
- ISIN(s):
- US8112922005
- LEI:
- Country:
- United States of America
- Address:
- 1 EVERTRUST PLAZA, JERSEY CITY
- Website:
- https://www.scynexis.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
SCYNEXIS, Inc. is a biotechnology company focused on the discovery, development, and commercialization of novel therapies for difficult-to-treat and drug-resistant infectious diseases. The company is pioneering a ground-breaking class of anti-fungal agents, referred to as "fungerps," to address the growing global health threat of antimicrobial resistance. Its pipeline is dedicated to creating innovative treatments for serious and life-threatening fungal infections that pose significant challenges in hospital settings, aiming to serve critical unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all SCYNEXIS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SCYNEXIS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SCYNEXIS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
